Chaplin, StevePatel, Vinod2025-04-032025-04-032015-09-04Chaplin S, Patel V. Xultophy: Combination therapy for the treatment of type 2 diabetes. Prescriber. 2015 September;26(17):32-34. doi: 10.1002/psb.1382.0959-66821931-225310.1002/psb.1382http://hdl.handle.net/20.500.14200/7361Xultophy is the first product to combine a basal insulin and an incretin mimetic for the treatment of type 2 diabetes. Here Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Vinod Patel outlines its place in therapy.enDiabetesPharmacologyArticle